Acutus Medical, Inc.AFIBNASDAQ
Loading
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 100.00% |
| Q4 2023 | -396.77% |
| Q3 2023 | -29.47% |
| Q2 2023 | 624.84% |
| Q1 2023 | -85.04% |
| Q4 2022 | 5.43% |
| Q3 2022 | -25.07% |
| Q2 2022 | -0.85% |
| Q1 2022 | -9.47% |
| Q4 2021 | -4.94% |
| Q3 2021 | 1.36% |
| Q2 2021 | -2.09% |
| Q1 2021 | 4.55% |
| Q4 2020 | 7.42% |
| Q3 2020 | 2.04% |
| Q2 2020 | 2.55% |
| Q1 2020 | 5.74% |
| Q4 2019 | -63.86% |
| Q3 2019 | 297.66% |
| Q2 2019 | 19.88% |
| Q1 2019 | 0.00% |